Sunshine Biopharma, Inc. (SBFM)
1.15
-0.02
(-1.71%)
USD |
NASDAQ |
Sep 03, 10:01
Sunshine Biopharma Market Cap : 2.747M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 02, 2026 | 2.794M |
| September 01, 2026 | 2.699M |
| August 31, 2026 | 2.675M |
| August 28, 2026 | 2.747M |
| August 27, 2026 | 3.033M |
| August 26, 2026 | 2.962M |
| August 25, 2026 | 2.723M |
| August 24, 2026 | 2.771M |
| August 21, 2026 | 2.771M |
| August 20, 2026 | 2.771M |
| August 19, 2026 | 2.794M |
| August 18, 2026 | 2.675M |
| August 17, 2026 | 2.675M |
| August 14, 2026 | 2.747M |
| August 13, 2026 | 2.866M |
| August 12, 2026 | 2.890M |
| August 11, 2026 | 2.938M |
| August 10, 2026 | 0.5985M |
| August 07, 2026 | 0.6034M |
| August 06, 2026 | 0.6868M |
| August 05, 2026 | 0.6525M |
| August 04, 2026 | 0.6427M |
| August 03, 2026 | 0.574M |
| July 31, 2026 | 0.574M |
| July 30, 2026 | 0.6034M |
| Date | Value |
|---|---|
| July 29, 2026 | 0.6034M |
| July 28, 2026 | 0.7016M |
| July 27, 2026 | 0.7506M |
| July 24, 2026 | 0.8144M |
| July 23, 2026 | 0.8389M |
| July 22, 2026 | 0.888M |
| July 21, 2026 | 0.8586M |
| July 20, 2026 | 0.8487M |
| July 17, 2026 | 0.8831M |
| July 16, 2026 | 0.8978M |
| July 15, 2026 | 0.9125M |
| July 14, 2026 | 0.942M |
| July 13, 2026 | 0.9567M |
| July 10, 2026 | 1.025M |
| July 09, 2026 | 1.050M |
| July 08, 2026 | 1.040M |
| July 07, 2026 | 1.020M |
| July 06, 2026 | 1.070M |
| July 02, 2026 | 1.035M |
| July 01, 2026 | 1.070M |
| June 30, 2026 | 1.030M |
| June 29, 2026 | 1.035M |
| June 26, 2026 | 1.070M |
| June 25, 2026 | 1.050M |
| June 24, 2026 | 1.001M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.966B |
| Alnylam Pharmaceuticals, Inc. | 35.53B |
| Anika Therapeutics, Inc. | 284.52M |
| Savara, Inc. | 1.101B |
| Vericel Corp. | 2.075B |
Market Cap Related Metrics
| PS Ratio | 0.0226 |
| Price to Book Value | 0.0998 |
| Price | 1.15 |
| Earnings Yield | -889.2% |